AM73
AM73 is a PGC-1α1 stabilizer. AM73 increases the expression levels of Ucp1 and Cidea in brown adipocytes, and enhances basal mitochondrial respiration and uncoupled respiration. AM73 regulates hypoxia, brown adipocyte differentiation, carbohydrate metabolism and insulin signaling pathways in brown adipocytes. AM73 alters the thermogenic process of white adipocytes. AM73 is applicable to the research of obesity and related metabolic disorders.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 931619-99-7
- 分子式: C18H13ClN2O5
- 分子量:372.76
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
AM73 (10 μM; 8 h) increases the level of EGFP-PGC-1α1 fusion protein in HEK 293-EGFPmPGC-1α1 cells[1].
AM73 (10 μM; 8 h) induces significant expression of thermogenic and mitochondrial PGC-1α target genes in fully differentiated immortalized mouse brown adipocytes[1].
AM73 (10 μM; 8 h) stabilizes endogenous PGC-1α protein in fully differentiated immortalized mouse brown adipocytes[1].
AM73 (10 μM; 8 h) increases basal mitochondrial respiration and uncoupled mitochondrial respiration in fully differentiated immortalized mouse brown adipocytes by approximately 13%[1].
AM73 (10 μM; 8 h) regulates numerous PGC-1α-associated gene pathways related to thermogenesis, metabolism and differentiation in fully differentiated immortalized mouse brown adipocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human embryonic kidney (HEK) 293-EGFPmPGC-1α1 stable cells (expressing EGFP-PGC-1α1 fusion protein)
-
Concentration:10 μM
-
Incubation Time:8 h
-
Result:Induced a 206.1% EGFP intensity increase relative to DMSO control, as measured by whole cell integrated fluorescence intensity median per well.
-
Cell Line:fully differentiated mouse immortalized brown adipocytes
-
Concentration:10 μM
-
Incubation Time:8 h
-
Result:Induced a 12-fold increase in Ucp1 gene expression, a ~4-fold increase in Cidea gene expression, and modest (≤2-fold) increases in the expression of other PGC-1α target genes including Tfam, Esrra, Prdm16, and Sod1, relative to DMSO control.
-
Cell Line:fully differentiated mouse immortalized brown adipocytes
-
Concentration:10 μM
-
Incubation Time:8 h
-
Result:Increased endogenous PGC-1α protein accumulation to levels comparable to cold-induced brown adipose tissue, as detected by immunoblotting.
化学情報
-
CAS 番号 931619-99-7
-
分子量 372.76
-
分子式 C18H13ClN2O5
-
SMILES
OC1=C(C(C2=CN(C3=NOC(C)=C3)C(C(C(C)=O)=C2)=O)=O)C=C(Cl)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
3T3-L1 preadipocyte-to-adipocyte differentiation
3T3-L1 preadipocytes are induced to differentiate after growth arrest using adipogenic media containing insulin, dexamethasone, and IBMX; differentiation is assessed by lipid-droplet accumulation, triglyceride increase, Oil Red O staining, and adipocyte-marker induction such as PPARγ and C/EBPα.
-
Large-size fat particle sorting
Large-size fat particle sorting is widely used to isolate cells up to 200 μm in diameter. Single-cell flow sorting will allow greater insight into adipocyte heterogeneity by identifying gene expression, protein composition, and metabolic signatures at the single-cell level.
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)